Ozmosi | Cetuximab beta Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Cetuximab beta

Alternative Names: Cetuximab beta, cmab-009, cmab009, cmab 009
Clinical Status: Active
Latest Update: 2026-01-06
Latest Update Note: Clinical Trial Update

Product Description

novel recombinant human/mouse chimeric epidermal growth factor receptor (EGFR) monoclonal antibody

Mechanisms of Action: EGFR Inhibitor

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Zhangjiang Biotechnology Limited Company
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cetuximab beta

Countries in Clinic: China

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Colorectal Cancer

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

CTR20170701

 CTR20170701

P3

Active, not recruiting

Colorectal Cancer

None

2025-04-29

Patient Enrollment|Start Date|Treatments|Trial Status

Recent News Events

Date

Type

Title

06/26/2024

News Article

 Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions